Search Results 1611-1620 of 20047 for Monitoring

  1. Prostate cancer screening: Should you get screened? - Mayo Clinic

    Learn about the pros and cons of prostate cancer screening to help you get ready to talk with your healthcare professional about your options.

  2. Sorafenib (oral route) - Side effects & dosage - Mayo Clinic

    Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, ...

  3. Neurology - Doctors - Mayo Clinic

    Fine, M.D.. Neurologist. Rochester, MN. Areas of focus: Vagus nerve stimulation, EEG, Subdural electrode monitoring, Video EEG monitoring, Epilepsy, Tonic- ...

  4. Cyclophosphamide (oral route, intravenous route) - Mayo Clinic

    Cyclophosphamide is also used for some kinds of kidney disease. Cyclophosphamide interferes with the growth of cancer cells, which are then destroyed by the ...

  5. Cefazolin (injection route) - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  6. William Tatum, D.O. - Mayo Clinic Faculty Profiles

    EEG and clinical neurophysiology. Dr. Tatum's research areas have included aspects of temporal lobe epilepsies, ambulatory EEG and video-EEG monitoring — ...

  7. Mukesh K. Pandey, Ph.D. - Mayo Clinic Faculty Profiles

    Molecular imaging is increasing its impact on patient care as it provides noninvasive imaging tools to detect, diagnose and monitor the disease progression and ...

  8. Calcium acetate (oral route) - Side effects & dosage - Mayo Clinic

    Calcium acetate is used to treat hyperphosphatemia (too much phosphate in the blood) in patients with end stage kidney disease who are on dialysis. Calcium ...

  9. Azithromycin (intravenous route) - Side effects & uses - Mayo Clinic

    However, this medicine will not work for colds, flu, or other virus infections. Azithromycin injection may be used for other problems as determined by your ...

  10. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

    ... Monitor and investigator. History of another invasive cancer within 3 years, with the exception that fully treated cancers with a remote probability of ...